JP2009532338A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2009532338A5 JP2009532338A5 JP2009500598A JP2009500598A JP2009532338A5 JP 2009532338 A5 JP2009532338 A5 JP 2009532338A5 JP 2009500598 A JP2009500598 A JP 2009500598A JP 2009500598 A JP2009500598 A JP 2009500598A JP 2009532338 A5 JP2009532338 A5 JP 2009532338A5
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- amino
- hydroxy
- pharmaceutically acceptable
- acceptable salt
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US78221106P | 2006-03-14 | 2006-03-14 | |
| PCT/US2007/064002 WO2007106869A1 (en) | 2006-03-14 | 2007-03-14 | Peptidomimetic inhibitors of psma,compounds comprising them, and methods of use |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2009532338A JP2009532338A (ja) | 2009-09-10 |
| JP2009532338A5 true JP2009532338A5 (https=) | 2011-04-28 |
Family
ID=38229662
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2009500598A Pending JP2009532338A (ja) | 2006-03-14 | 2007-03-14 | Ｐｓｍａのペプチド模倣体阻害剤、それらを含む化合物、およびそれらの使用方法 |
Country Status (9)
| Country | Link |
|---|---|
| US (3) | US7696185B2 (https=) |
| EP (1) | EP1999136B1 (https=) |
| JP (1) | JP2009532338A (https=) |
| CN (1) | CN101443340B (https=) |
| AU (1) | AU2007226542B2 (https=) |
| CA (1) | CA2645809C (https=) |
| ES (1) | ES2397973T3 (https=) |
| PL (1) | PL1999136T3 (https=) |
| WO (1) | WO2007106869A1 (https=) |
Families Citing this family (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2700234T3 (es) | 2007-06-26 | 2019-02-14 | Univ Johns Hopkins | Inhibidores marcados del antígeno de membrana específico de la próstata (PSMA), evaluación biológica y uso como agentes para la obtención de imágenes |
| PL2187965T3 (pl) | 2007-08-17 | 2020-05-18 | Purdue Research Foundation | Koniugaty wiążący psma ligand-łącznik i sposoby ich zastosowania |
| WO2010045598A2 (en) * | 2008-10-17 | 2010-04-22 | Purdue Research Foundation | Psma binding ligand-linker conjugates and methods for using |
| WO2010149666A1 (en) * | 2009-06-22 | 2010-12-29 | Medexis S.A. | Methods for treating neoplasia |
| EP2338892A1 (en) | 2009-12-18 | 2011-06-29 | Bayer Schering Pharma Aktiengesellschaft | Prostate specific membrane antigen inhibitors |
| CA2790577A1 (en) * | 2010-02-25 | 2011-09-01 | Purdue Research Foundation | Psma binding ligand-linker conjugates and methods for using |
| US9951324B2 (en) | 2010-02-25 | 2018-04-24 | Purdue Research Foundation | PSMA binding ligand-linker conjugates and methods for using |
| JP5657902B2 (ja) * | 2010-03-17 | 2015-01-21 | 株式会社コスモステクニカルセンター | ポリオキシアルキレンステロールエーテル誘導体及び／又はポリオキシアルキレンスタノールエーテル誘導体、及びそれを含有する外用剤組成物 |
| US9328129B2 (en) * | 2010-11-12 | 2016-05-03 | Washington State University | Peptidomimetic inhibitors of PSMA |
| WO2012174136A1 (en) * | 2011-06-15 | 2012-12-20 | Cancer Targeted Technology Llc | Chelated psma inhibitors |
| WO2013173583A1 (en) | 2012-05-16 | 2013-11-21 | Cancer Targeted Technology, Llc | Psma inhibitors |
| EA201590783A1 (ru) | 2012-11-15 | 2015-11-30 | Эндосайт, Инк. | Конъюгаты для доставки лекарственных средств и способы лечения заболеваний, вызванных клетками, экспрессирующими psma |
| PL2970345T3 (pl) * | 2013-03-15 | 2019-12-31 | Cancer Targeted Technology Llc | Znakowane 18F środki do obrazowania PET ukierunkowane na PSMA |
| EP2842578B1 (en) | 2013-08-27 | 2018-06-27 | GILUPI GmbH | Diagnostic device for the detection of biomarkers |
| EP3456700A1 (en) | 2013-10-18 | 2019-03-20 | Deutsches Krebsforschungszentrum | Labeled inhibitors of prostate specific membrane antigen (psma), their use as imaging agents and pharmaceutical agents for the treatment of prostate cancer |
| EP3533473A3 (en) | 2013-11-14 | 2019-12-18 | Endocyte, Inc. | Compounds for positron emission tomography |
| US10383912B2 (en) * | 2014-08-18 | 2019-08-20 | Washington State University | Tunable pH-sensitive linker for controlled drug release |
| US10188759B2 (en) | 2015-01-07 | 2019-01-29 | Endocyte, Inc. | Conjugates for imaging |
| US9808538B2 (en) * | 2015-09-09 | 2017-11-07 | On Target Laboratories, LLC | PSMA-targeted NIR dyes and their uses |
| AU2017311510B2 (en) | 2016-08-10 | 2021-11-18 | Cancer Targeted Technology Llc | Chelated PSMA inhibitors |
| CN112368024A (zh) | 2018-04-17 | 2021-02-12 | 恩多塞特公司 | 治疗癌症的方法 |
| IL287989B2 (en) * | 2019-05-13 | 2025-07-01 | Bracco Imaging Spa | Modified cyanine dyes and their conjugates |
| CN114096264B (zh) | 2019-05-20 | 2025-03-14 | 因多塞特股份有限公司 | 制备psma缀合物的方法 |
| WO2021046233A1 (en) | 2019-09-03 | 2021-03-11 | Cancer Targeted Technology Llc | Chelate-containing psma inhibitors |
| CN113117100B (zh) * | 2019-12-31 | 2024-03-01 | 广东精观生物医药科技有限公司 | 一种靶向psma的荧光分子探针及其制备方法和应用 |
| CN111675747B (zh) * | 2020-07-30 | 2021-04-27 | 中国医学科学院医药生物技术研究所 | 抗肿瘤药物和用途 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US782211A (en) | 1904-05-23 | 1905-02-07 | George W Sturgis | Vending-wagon. |
| RU2218179C2 (ru) * | 1996-06-17 | 2003-12-10 | Гилфорд Фармасьютикалз Инк. | СПОСОБЫ ЛЕЧЕНИЯ РАКА С ПРИМЕНЕНИЕМ ИНГИБИТОРОВ NAALADазы |
| ATE362107T1 (de) * | 2000-11-20 | 2007-06-15 | Eastern Virginia Med School | Verfahren und vorrichtungen zum quantitativen nachweis eines prostata-spezifischen membranantigens und anderer prostatamarker |
| ATE337011T1 (de) * | 2001-02-07 | 2006-09-15 | Beth Israel Hospital | Modifizierte psma-liganden und deren verwendung |
| CA2474616A1 (en) * | 2002-01-28 | 2003-08-07 | Medarex, Inc. | Human monoclonal antibodies to prostate specific membrane antigen (psma) |
-
2007
- 2007-03-14 CA CA2645809A patent/CA2645809C/en active Active
- 2007-03-14 PL PL07758547T patent/PL1999136T3/pl unknown
- 2007-03-14 ES ES07758547T patent/ES2397973T3/es active Active
- 2007-03-14 CN CN2007800176204A patent/CN101443340B/zh active Active
- 2007-03-14 US US11/686,272 patent/US7696185B2/en not_active Ceased
- 2007-03-14 JP JP2009500598A patent/JP2009532338A/ja active Pending
- 2007-03-14 WO PCT/US2007/064002 patent/WO2007106869A1/en not_active Ceased
- 2007-03-14 EP EP07758547A patent/EP1999136B1/en active Active
- 2007-03-14 AU AU2007226542A patent/AU2007226542B2/en active Active
-
2010
- 2010-01-22 US US12/691,957 patent/US8293725B2/en active Active
- 2010-07-13 US US12/835,257 patent/USRE42275E1/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2009532338A5 (https=) | ||
| ES2397973T3 (es) | Inhibidores peptidomiméticos del PSMA, compuestos que los comprenden y métodos de utilización | |
| JP2016153410A5 (https=) | ||
| WO2008101231A2 (en) | Methods and compositions for treating and diagnosing kidney disease | |
| US20210206774A1 (en) | Molecular containers and methods of making and using same | |
| CN103260652B (zh) | 显示不依赖于浓度的响应性的cest系统 | |
| KR20240046416A (ko) | 이중 표적화 화합물 및 이의 제조 방법과 응용 | |
| US7998462B2 (en) | Linkers for anchoring targeting ligands | |
| US20100183658A1 (en) | Novel Compounds for Enhancing MHC Class II Therapies | |
| JP2019519530A (ja) | ペグ化されたカルフィルゾミブ化合物 | |
| JP2010174013A (ja) | 組織ダメージの治療と予防 | |
| RU2003137593A (ru) | Соединения на основе пептидов для направленной доставки к рецепторам интегринов | |
| US20250177540A1 (en) | Stable compositions of pegylated carfilzomib compounds | |
| JP2014516993A5 (https=) | ||
| KR20120047263A (ko) | ε폴리라이신 결합체 및 이의 용도 | |
| US10702546B2 (en) | Bile acid oligomer conjugate for novel vesicular transport and use thereof | |
| US11414455B2 (en) | Toll-like receptor 2 ligands and methods of making and using thereof | |
| AU2021259858B2 (en) | GPER proteolytic targeting chimeras | |
| US20240190790A1 (en) | Conjugates derived from non-steroidal anti-inflammatory drugs and methods of use thereof in imaging | |
| CN105188703A (zh) | 荧光-hap：用于细胞中的hbv核的诊断性染色剂 | |
| TW202412850A (zh) | 用於治療代謝和肝臟病症之藥物配方及方法 | |
| Urbanovsky et al. | Lanthanide complexes of DO3A–(Dibenzylamino) methylphosphinate: effect of Protonation of the Dibenzylamino Group on the water-exchange rate and the binding of human serum albumin | |
| CA2739445A1 (en) | Site specific n-terminal modifications of proteins and conjugate formation | |
| WO2021202621A2 (en) | Modified peptide nucleic acid compositions | |
| US8791075B2 (en) | Methods and compositions for inhibition of BCL6 repression |